UroGen Pharma Ltd. (URGN)
36.83
-0.15
(-0.41%)
USD |
NASDAQ |
Oct 09, 16:00
36.83
0.00 (0.00%)
After-Hours: 20:00
UroGen Pharma Profit Margin (Quarterly) : -19.81% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -19.81% |
| March 31, 2026 | -46.26% |
| December 31, 2025 | -69.68% |
| September 30, 2025 | -121.3% |
| June 30, 2025 | -206.2% |
| March 31, 2025 | -216.5% |
| December 31, 2024 | -152.7% |
| September 30, 2024 | -93.93% |
| June 30, 2024 | -152.9% |
| March 31, 2024 | -171.9% |
| December 31, 2023 | -110.6% |
| September 30, 2023 | -104.9% |
| June 30, 2023 | -114.2% |
| March 31, 2023 | -175.7% |
| December 31, 2022 | -156.1% |
| September 30, 2022 | -160.5% |
| June 30, 2022 | -160.8% |
| March 31, 2022 | -209.3% |
| Date | Value |
|---|---|
| December 31, 2021 | -175.9% |
| September 30, 2021 | -266.2% |
| June 30, 2021 | -201.2% |
| March 31, 2021 | -346.5% |
| December 31, 2020 | -383.2% |
| September 30, 2020 | -832.6% |
| June 30, 2020 | -8.43K% |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | -124.9K% |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | -7.26K% |
| June 30, 2018 | -4.95K% |
| March 31, 2018 | -2.78K% |
| December 31, 2017 | -3.08K% |
| September 30, 2017 | -3.81% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Xencor, Inc. | -42.42% |
| MeiraGTx Holdings Plc | 49.99% |
| Insmed, Inc. | -3.11% |
| Ironwood Pharmaceuticals, Inc. | 45.37% |
| Viking Therapeutics, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -44.36% |
| Return on Invested Capital | -232.7% |
| Gross Profit Margin (Quarterly) | 90.93% |
| Operating Margin (Quarterly) | 0.15% |
| Return on Net Operating Assets | -145.6% |